Nintx

Nintx was founded by two experienced PhD scientists, Dr. Nintx is a startup with innovation as core business, right at the center of the strategy, heavily based on advanced technologies, coupled with the Brazilian biodiversity, the most biologically diverse in the world, to develop the next generation of therapies. Some of Nintx’s proprietary technologies include xGIbiomics®, which closely emulates the human gastrointestinal digestive system and microbiome, and GAIApath®, an artificial intelligence and analytics solution to map and select medicinal plants with the ability to modulate targets and the microbiome concomitantly. Nintx’s cutting-edge technologies and concepts will be key in the future development of multi-target therapies. At Nintx, we are bringing together the most advanced technologies with the best professionals, the strongest partners and investors to generate a unique and scalable platform capable of creating a therapeutic powerhouse fueled by our incredible biological richness.” Miller Freitas Co-Founder & CEO. We believe Nintx is such player and can inspire others to follow.” Stephani Saverio Co-Founder & Non-Executive Board Member. Nintx secured a seed investment round of US$ 3 million, led by Sao Paulo-based deep tech venture capital firm Pitanga, through its newly launched investment vehicle Pitanga Redux. Nintx has a pipeline of innovative research programs, many of them in partnership with companies and research institutes.